Throat Cancer Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027

 The global market for throat cancer is likely to rise steadily over the forecast period due to the growing prevalence of throat cancer and the growing efforts being taken by government bodies to eliminate the threat of throat cancer. The global throat cancer market is studied in detail in a new research report from Market Research Future (MRFR), which studies the historical growth trajectory of the global throat cancer market to present readers with a detailed analysis of the market’s likely growth prospects over the forecast period. The major drivers and restraints affecting the global throat cancer market are profiled in the report to provide a clear idea about their impact on the market’s progression over the forecast period. The key players operating in the global throat cancer market are also profiled in the report to give readers an idea of the market’s competitive landscape.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1792 

The global throat cancer market has been driven in the last few years by the growing prevalence of throat cancer around the world. Throat cancer is caused by lifestyle factors such as excessive smoking and drinking. This has become an increasingly popular habit among urban users in recent years, leading to a growing prevalence of throat cancer. Smoking is a major causative agent for throat cancer, as tobacco is a major aid in the formation and proliferation of cancerous tumors. The growing global popularity of smoking is likely to remain a major driver for the global throat cancer market over the forecast period, as urban users are becoming increasingly entrenched in the smoking habits with their increasingly hectic work schedules and lifestyles.

The growing geriatric population is also likely to be a key driver for the global throat cancer market, as geriatric people are more likely to suffer from throat cancer than younger demographics. The regular consumption of piping hot beverages is also linked with the formation of throat cancers, leaving the elderly more prone to the disease than younger demographics.

Competitive Analysis:

Leading players in the global throat cancer market include Amgen Inc., Celgene Corporation, Engeneic Ltd., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis, F. Hoffman-La Roche AG, Eli Lilly and Company, and Bristol-Myers Squibb.

In April 2019, British researchers in Guy’s & St. Thomas’ NHS Trust in London came up with a new way to get rid of throat cancers using a robotic apparatus. The new robotic apparatus allows for smooth and precise removal of throat cancers. The measure comes in the face of rising evidence that throat cancer is becoming a considerable health threat in the UK: throat cancer has become as common in people in their 50s as it is among people in their 80s, and the prevalence of head and neck cancers has risen by 31% in the last 25 years. Measures such as this are likely to become increasingly popular over the forecast period.

Segmentation:

The global throat cancer market is segmented on the basis of type and treatment.

By type, the global throat cancer market is segmented into pharyngeal and laryngeal cancer, with laryngeal cancer holding the larger share of the two and expected to exhibit robust growth over the forecast period.

By treatment, the global throat cancer market is segmented into radiation therapy, surgery, chemotherapy, and others. Radiation therapy is likely to retain the dominance in the global throat cancer market over the forecast period due to its widespread use in the treatment of throat cancer.

Regional Analysis:

North America is the leading regional market for throat cancer and is likely to retain the position over the forecast period due to the growing prevalence of throat cancer in the region and the growing demand for advanced treatments to treat the disease. The growing use of innovative treatment methods in the region is also likely to be a major driver for the throat cancer market over the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/throat-cancer-market-1792 

Capnography Market Foraying into Emerging Economies 2020-2027

 Market Scenario

The global capnography market 2020 is poised to mature during the forecast period (2018 to 2027) at a CAGR of 19.5%. 

Market Highlights

The paediatric population, the number of heart disease patients and rising elderly population are projected to fuel business growth. Increase in tobacco intake internationally, increasing the patient suffering from lung cancer. The main causes of lung cancer and asthma are smoking, air pollutants and increasing cases of infections. During the forecast era, the global capnography market is expected to rise due to factors such as innovation, technical developments and capnography product advancements. Healthcare bodies such as the European Resuscitation Council, the American Society of Anesthesiologists, and others made a strong recommendation about capnography to compulsorily include capnography devices in healthcare facilities. This fuels the growth of the capnographic world market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1535 

Market Scope

Companies show a great deal of interest in the Capnography market, as they feel there are huge opportunities and gaps between market demand and device supply. Thus, firms are showing more interest in mergers and acquisitions to introduce the best cure that meets market requirement. Countries like India and China, as compared to other countries in this region, are more focused market for global market players due to the huge patient population and growing purchasing power. Japan is a well-developed country with advanced healthcare systems and technology, while developing countries continue to focus on new treatment technology.

Segmental Analysis

The global capnography market is analyzed on the basis of application, devices, type, and end-user. 

The global capnography market on the basis of type is bifurcated into capnograph and disposable.  Capnograph is further subdivided into three major segments, namely, sidestream capnography, mainstream capnography, and micro stream capnography. Mainstream capnography is further sub-divided handheld monitor, sand alone monitor, and multi-parameter monitor.

Based on device, the global capnography market is segmented into stand-alone monitors, handheld monitors, and others.

Based on application, the global capnography market is divided into pain management, procedural sedation, emergency medicine, critical care, and general floor.

Based on end-user, the global capnography market is segmented into clinics, hospitals, and ambulatory surgical centers.

Regional Summary

The global demand for capnography research is segmented into the Americas, Europe , Asia-Pacific and the Middle East and Africa, based on area.

Leading to the increasing incidence of chronic diseases in the elderly population and the increasing frequency of asthma in paediatrics the American market is expected to dominate the global capnography industry. Due to the expansion of advanced products in this region North America dominates the global capnography market. As approved by government bodies, Latin America is seeing substantial growth in the capnography industry due to expanded usage of capnography instruments in health care facilities. Owing to an unhealthy lifestyle and high-stress level effects, the growing problems of respiratory disorders have contributed to substantial growth in that sector. Excellent reimbursement scenario for cancers is also very effective driver for capnography instruments, particularly in the U.S., as it minimises the patient's financial burden.

The European economy is the second highest in the capnographic world market. Business development in this area stems from government investment and healthcare sector support. But increasing numbers of surgeries and changing habits have led to demand growth in this area.

Asia-Pacific is anticipated to account for the fastest growing region due to the rising population ageing and increasing disease prevalence. Owing to growing healthcare spending and the awareness of the capnography technique, the Asia-Pacific capnography market is anticipated to develop during the forecast period. Countries like India and China are more focused on the global capnography industry, due to the growing buying power and population relative to other developed countries.

Competitive Dashboard

Nonin medical Inc, Dreagerwerk AG & CO. KGaA, Medtronic, Masimo, Nihon Kohden Corporation, Care fusion cooperation, Covidien Ltd, Edan Instruments, Inc., Diamedica Limited,Hill Rom Holding Inc, Welch Allyn, Koninklijke Philips N.V., Smiths Medical Inc, and BD are some of the msjor players of the market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/capnography-market-1535 

Medical Holography Market Growth, Trends and Value Chain 2020-2027

 Market Overview

Market Research Future (MRFR) believes that the medical holography market can thrive at a stunning rate of 33.7% over the analysis period (2019-2025).

Primary Drivers and Impediments

Despite the fact that the medical holography industry is still in the embryonic stage, it showcases the potential to be a game-changer for the medical imaging sector in the near future. Medical holography is a crucial aspect of molecular imaging in preclinical research and clinical diagnostics in numerous therapeutic areas. Given the potential use-cases of holography in interventional and diagnostic imaging fields, a number of research activities are underway, which should foster the growth prospects of the global market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1519 

Accelerated number of R&D activities initiated by biotechnological and pharmaceutical firms seem to be solidifying the foundation for biomedical researches. The surge in R&D initiatives should work in favor of the global market. Introduction of holographic interaction and visualization technologies that facilitate non-invasive surgeries and improve the safety profile can benefit the global market. Medical holography technology helps yield enhanced patient outcomes, and is therefore, likely to experience higher demand among patients as well as physicians in the future. Technological developments including inclusion of miniaturized light emitting diodes and innovative pico-like projectors for delivery of highly clear holographic images should also foster the demand in the years to come.

Segmental Status

Product, application and end user are the major segments as per which the medical holography market has been considered in the MRFR study.

Key products highlighted in the report are holography microscopes, holographic displays, holography software, holoscopes and holographic prints. The lead has been taken by holographic displays, as these find widespread use in medical education and diagnostic imaging.

Top applications of medical holography are medical imaging (dentistry, ophthalmology, orthopedics, urology, and others), biomedical research and medical education. Medical imaging could emerge as the fastest advancing segment in the market owing to the surging burden of various chronic disorders, which boosts the application scope of holography technology.

Key end users are academic medical centers, hospitals and clinics, pharmaceutical and biotechnology companies and research laboratories.

Regional Study

The global market can be regionally categorized into APAC or Asia Pacific, the Americas, MEA or Middle East & Africa and Europe.

America should prevail as the most profitable market for medical holography in the coming years, on account of high frequency of research activities conducted by most of the established firms in the region. Rising healthcare spending and increased adoption of modern technologies over conventional methods can also boost the influx of medical holographic products in the region. Mounting burden of various diseases as well as the rise in clinical urgency with respect to screening technologies like medical holography and their high accessibility in the region also foster market growth in the region.

The European market exhibits significant growth potential and should maintain its steady pace backed by the presence of a developed healthcare sector and the surge in clinical use cases of holography products. Medical imaging, digital holograms and holographic display technology are increasingly being used in the education sector and also in hospital teaching. With growing emphasis on structural biology across various medical schools, major players are striving to design advanced holographic prints as well as holography software that facilitate effective medical teaching. Besides, players are working on developing 3D kits for doctors and medical students to carry out efficient practice dissections and surgeries without the need for actual organs and bodies.

The APAC market is expanding at a consistent rate and should reach new heights over the review period, thanks to the extensive deployment of advanced holography products in several medical facilities as well as the surge in government efforts aimed at healthcare development. With growth in investments in medical facilities, technological advances in surgical rooms and emerging trend of personalized medicines, the medical holography market in Asia Pacific is bound to witness rapid growth in the next few years.

Reputed Vendors

Top companies active in the global market for medical holography include Lyncée Tec SA, EON Reality Inc., Realview Imaging Ltd., Zebra Imaging, Inc., Echopixel, Nanolive SA, Mach7 Technologies Limited, Zspace, Inc., Ovizio Imaging Systems NV/SA, Holoxica Limited, to mention a few.

Latest News

November 2020

Holoxica has completed the initial development stage of the 3D holographic system (first ever glasses-free technology) for healthcare professionals. The COVID-19 outbreak has forced patients to opt for remote healthcare, which is why Holoxica has designed its latest holistic 3D system, Holo-medicine, for enhanced remote consultations. The medical holography system helps make the health conditions as well as the surgical procedures clearer, while bringing down the stress faced by the healthcare system.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-holography-market-1519 

Cervical Dystonia Market Growth, Trends and Value Chain 2020-2027

 Cervical dystonia is a neurological movement disorder associated with involuntary movement of neck. It is also known as spasmodic torticollis. As per study it was estimated that women are more prone to get this disorder.

According to a recent study report published by the Market Research Future analysts, the global cervical dystonia market is currently dynamic and growing at a moderate pace. The growth of the market is mainly due to increase in prevalence of Parkinson’s disease, development of new drugs and therapies by players, and greater involvement of the companies in research and development. Besides that, current unmet needs for the cervical dystonia also presents great opportunities for the market players to enter into this market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1416 

That being said, there are few hurdles in the growth of this market such as high cost involved in the research and development leading to the increased cost of the drug, less awareness about the severity of the condition in developing and under developed regions. These factors hinder the cervical dystonia market growth. Global cervical dystonia market is expected to grow at a CAGR of 5% during forecasted period 2017-2023.

Experts say, exciting times are ahead for the cervical dystonia market, as the market events noted above are due to occur against the backdrop of a steadily growing cervical dystonia prevalent population. With the clinical unmet need for better diagnostic tools and treatment options for the affected population, cervical dystonia remains an attractive neurological disorder for drug developers.

Global Cervical Dystonia Market - Competitive Analysis

The global market consist of players such as ALLERGAN (Ireland), Solstice Neurosciences LLC (U.S.), Ipsen Biopharmaceuticals Inc. (France), Merz Inc (U.S.), US WorldMeds, LLC (U.S.) Addex Therapeutics (Switzerland), Revance Therapeutics, Inc.(U.S.), and many other. These are some of the prominent players at the forefront of competition in the global cervical dystonia market and are profiled in MRFR Analysis report.

The global cervical dystonia market is a dynamic market with number of drugs and therapies available in the market. There are few number of companies involved in the development of the drugs which are now widely used all across the world for the treatment of cervical dystonia. There are great developments happening in cervical dystonia therapeutics space.

Due to increasing prevalence of cervical dystonia globally many of the companies are in the race to introduce better oral treatment for cervical dystonia. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Revance Therapeutics Inc. in 2016 initiated a Phase II study of RT002 for the treatment of cervical dystonia. The Company completed its Phase II program recently. In November 2017, the company announce the completion of its Phase II program with a positive results. The company now plans to carry out Phase 3 Program for RT002 Injectable to treat Cervical Dystonia.

ALLERGAN has introduced BOTOX (onabotulinumtoxinA) for treatment of cervical dystonia. It is prescribed to 16 and older people suffering from cervical dystonia. It is an intramuscular drug.

Solstice Neurosciences LLC has introduced MYOBLOC (rimabotulinumtoxinB), which was the first FDA-approved treatment for cervical dystonia. It is used for the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.

Ipsen Biopharmaceuticals Inc. a French company introduced Dysport (abobotulinumtoxinA) for the treatment of adults with cervical dystonia.

Global Cervical Dystonia Market - Regional Analysis

Americas has the largest cervical dystonia market. Increasing people suffering from cervical dystonia in America has help to increase the market in this region. Beside this, rise in neurotoxin market, increase in treatments for muscle movement disorders and increasing aging population in this region has fuelled the growth of this market in American region. Due to a huge aging population in Canada the market is developing at a significant rate in this region. As per study, women are more prone to cervical dystonia than men.

Europe has the second largest market which majorly contributed by UK, Germany and France. Well-developed healthcare sector, improved infrastructure and increase in healthcare spending have increased the market in this region.

Asia Pacific is expected to be the fastest growing region for the cervical dystonia market. Asia Pacific is the developing region and a huge population base in this region is the major factor for the growth of the market. Beside this continuous development in healthcare sector and increasing aging population in Asia Pacific has provided fuel for the growth of the market. India and China are the major market of the cervical dystonia.  Due to less development in medical and healthcare sector, Middle East and Africa region contributes least in the cervical dystonia market at present.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cervical-dystonia-market-1416 

Surgical Instrument Tracking Systems Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027

 Global Surgical Instrument Tracking System Market is expected to register a CAGR of 15.1% during the forecast period and expected to hit USD 567.44 Million by 2027.

Surgery requires a precise assortment of instruments, as many as 200 for a lengthy, complicated procedure, constantly organized before, during, and after the operation. The infection can be incurred by patients if the surgical instrument is left inside patients. According to a research paper published in the National Center for Biotechnology Information (NCBI), the ratio of patients with surgical instruments left inside in 2017 was between 0.3 to 1.0 per 1,000 abdominal operations. There are 1,500 instances of retained surgical instruments based on 28 million estimated operations performed in the US on an annual basis. The requirement of better inventory and asset management practices and growth of the surgical instruments market are expected to drive the surgical instrument tracking system market growth during the forecast period of 2020 to 2027. The Obesity Surgery Society of India reported that there had been a 100-fold increase in weight-loss surgeries in India in just 15 years. The number of weight-loss surgeries in India has shot from 200 in 2004 to a whopping 20,000 in 2019. Almost 1.3 million pregnant women had their babies by C-section in the United States in 2017, according to data released earlier this year [pdf] by the Centers for Disease Control and Prevention (CDC).

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1391 

Other factors that drive market growth is to meet the unique device identification rules of the Food and Drugs Administration (FDA). Certain devices intended for multiple use and reprocessed before each use will require direct marking of the UDI on the device itself (many of these are surgical instruments). Product marking will be essential for latex gloves, catheters, basic surgical sponges, and other commodity supplies. However, the advancement and rising adoption of robotic surgery might reduce the number of surgical instruments used per surgery. Thus, government regulations and the implantation of new norms for instrument tracking are anticipated to increase the rate of market growth.

Segment Analysis

Global Surgical Instrument Tracking System Market has been segmented based on Components, Technology, and End-Use.

The market, based on components, has been segregated into hardware, software, services, and others. The hardware segment is further sub-segmented into tags, readers, and others.

Based on technology, the surgical instrument tracking system market has been divided into barcode tracking and radio frequency identification.

On the basis of end-use, the surgical instrument tracking system market is bifurcated into hospitals and others.

Regional Analysis

Global Surgical Instrument Tracking System Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to hold the largest share of the global surgical instrument tracking system market during the assessment period owing to the regulatory reforms. Some of the renowned companies operating in the region include Fortive Corporation, Becton, Dickinson and Company, and Key Surgical. A large number of surgical procedures are expected to fuel the surgical instrument tracking system market in the region. The market in Europe is expected to propel during the forecast period, owing to factors such as rising government initiatives and the increasing number of vendors involved in the barcoding of instruments. In the UK, the Department of Health and MHRA guidance states that hospitals need to track instruments to at least tray level. Using GS1 barcodes means all instruments are traceable from production to the point of care. For patient safety, this is vital as it helps save track instruments. Lost instruments can cost a 500-bed hospital over £100,000 (USD 13,317) per year. Major companies are focusing on adopting international norms in Asian countries to increase patient safety and efficiency of inventory management. For example, Elite Medical, an Australian supplier of surgical tools with a presence of over 30 years in the region, provides instruments and tray tags, which includes smart tags, plastic tray tags, metal tray tags, RFID mesh tray tags, and others for tracking. The surgical instrument tracking system market in the Middle East & Africa is expected to witness a modest market growth rate from 2020 to 2027.

Key Players

MRFR recognizes the following companies as the Key Players in the global surgical instrument tracking system market— Getinge AB (Sweden), Becton, Dickinson and Company (US), Fortive Corporation (US), B. Braun Melsungen AG (Germany), Steris PLC (Ireland), Stanley Black & Decker, Inc. (US), Material Management Microsystems (US), Key Surgical (US), Haldor Advanced Technologies (US), TGX Medical Systems (US) and Others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-instrument-tracking-system-market-1391 

Ventilator-Associated Pneumonia Market to Witness Widespread Expansion During 2020-2027

 Patients in critical care require aid for respiration. Many of them suffer from disease like heart disease which require continuous monitoring by healthcare staff in intensive care unit. Ventilator- associated pneumonia is prevalent among patients admitted to ICUs. It is a significant cause of morbidity and mortality in ICU. This disease results from contaminated pathogen secretions in the lungs. Prolonged use of ventilators in ICU favour the growth of this market. Increase in hospital acquired infection is also another factor contributing for the growth of this market. Prevention of ventilator-associated pneumonia is important to protect the health of patients suffering from life threating diseases.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1377 

Global Ventilator-associated Pneumonia (VAP) Market - Competitive Analysis

June, 2016 - AstraZeneca had announced that the European Commission (EC) has granted marketing authorisation for Zavicefta, which a combination antibiotic for the treatment of patients with serious Gram-negative bacterial infections requiring hospitalisation. AstraZeneca is a global, innovation-driven biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas which are respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology and infection and neuroscience. Company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. As per company reports, hospital-acquired pneumonia (HAP) denotes the development of lung infections after a patient has been hospitalised for a minimum of 48 hours. However, after 48 hours, the infection develops during the use of incubation and mechanical ventilation, the condition is then called ventilator associated pneumonia (VAP). VAP is generally a severe illness, with patients requiring treatment in the intensive care unit (ICU). The approval includes intravenous use of Zavicefta for the treatment of patients suffering from intra-abdominal infections (cIAI); Complicated urinary tract infections (cUTI), including pyelonephritis; hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP); and, the treatment of aerobic Gram-negative infections in adult patients who have limited treatment options. Zavicefta has been developed in response to the urgent need for new antibiotics to treat serious infections that are becoming increasingly resistant, such as multi-drug resistant P. aeruginosa, carbapenem-resistant Gram-negative pathogens, and ESBL-producing Enterobacteriaceae.

Jan, 2016 - Cepheid announced diagnostic collaboration with medimmune and combacte to facilitate clinical trials of new monoclonal antibodies to prevent serious infectious diseases. This Collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, and COMBACTE, a European public/private partnership set up to promote the development of new drugs in the anti-infectives field, to develop a series of rapid diagnostic tests to identify Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) in respiratory secretions of mechanically ventilated patients. These tests will be used to help identify patients for MedImmune's MEDI4893 and MEDI3902 clinical programs, which are being conducted within the COMBACTE consortium to explore the use of biologics in preventing ventilator associated pneumonia (VAP) infections in intensive-care-unit (ICU) patients.

Philips Healthcare is one of the major market player in ventilation devices with its products named Respironic NM3, Respironic V680 and Respironic Trilogy 202.

Medtronic plc. is another major market player in this market with product like Puritan Bennet 980, Newport HT70 and Newport e360.

ResMed manufactures ventilation devices named Astral 150 and Astral 100.

Global Ventilator-associated pneumonia (VAP) Market   - Regional Analysis

Globally, Ventilator-associated pneumonia (VAP) market consists of four regions Americas, Europe, Asia Pacific and Middle East & Africa. America is the largest market for Ventilator-associated pneumonia (VAP) whose growth is contributed to increase in prevalence of smoking leading to lung diseases, large number of patients suffering from chronic heart diseases and demand of mechanical ventilators. The market is growing continuously in Europe due to extensive demand of medical devices in hospitals, and increasing healthcare expenditure. Asia Pacific is expected to be the fastest growing market owing to increase in environmental pollution, high incidence of asthma & chronic obstructive pulmonary disease and large patient pool. Moreover, Awareness regarding prevention of hospital acquired infection, pneumonia and quality control measures taken by hospitals for control of nosocomial infection favour the growth of this market. Increasing ageing population and incidence of infectious disease too contribute for the growth of this market in Asia Pacific. On the other hand, the Middle East & Africa region are likely to have a limited but steady growth in the market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377 

Surgical Chips Market to Witness Widespread Expansion During 2020-2027

 The global market for surgical chips is anticipated to surge at a remarkable CAGR throughout the forecast period (2017-2027), asserts Market Research Future (MRFR). A surgical chip is a recognizing coordinated circuit gadget encased in silicate glass and embedded in the body of an individual.

Drivers and Restraints

The global surgical chips market is growing at a luxurious pace; primarily owing to the increasing penetration of technology in healthcare sector, and growing awareness about the use of surgical chips for patient tracking, medical records management, and healthcare quality control. MRFR experts report that the global surgical chips market is at a flourishing stage and is predicted to gain further prominence over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1310 

The market is also inundated with market players constantly indulging in research and development activities to gain a competitive edge over other companies. For instance, in August 2018, researchers at Brigham and Women’s Hospital (BWH) developed 3D bioprinted tubular structures that imitate the human body’s vessels. The 3D bioprinting technique allows for better replications of the tissues’ properties and could potentially offer a viable solution for damaged tissue.

Market Segmentation

The global surgical chips market has been segmented based on type, end-user, and application.

The types in the global market are DNA Chips, brain chips, lab chips, protein chips, tissue chip and others. The DNA chips market is gaining significant traction from several factors, such as large-scale initiatives in the related field, increasing demand for personalized medicine, miniaturization of DNA chips, escalating need for early detection of cancer and consequent diagnosis and therapeutics.

By end user, the market is segmented into hospitals, clinics, research facilities and others. With constant research and development activities undertaken by companies, number of research facilities have cropped up to meet with these demands. Thus, continuous innovations and discoveries are possible only with high availability of research facilities.

By application, the market is segmented into cancer diagnosis and treatment, gene expression, SNP genotyping, genomics, clinical diagnostics, and others. Rising cases of cancer patients, changing lifestyle and unhealthy eating habits have led to subsequent surge in the cancer diagnosis and treatment market.

Regional Analysis

The market is regionally split into the regions of the Americas, Europe, Asia Pacific, and Middle East & Africa.

North America is the largest market for surgical chips globally on account of increasing healthcare R&D expenditure and highly enhanced healthcare technology. The need to curtail costs, growth and increased use of shifting commodity prices also work in favor of the regional market.

MRFR reports that Europe is the second-largest market for surgical chips due to high strength of private label brands coupled with increased competition amongst market players. Constant technological innovations and continuous R&D activities enhance the market development as well.

On the other hand, Asia Pacific is presumed to be a growing market for surgical chips market, demonstrating a spectacular growth on account of government funding and support along with improving economy and constant efforts put by market players to achieve success in the market. For instance, in August 2018, IIT Kharagpur set up India's pioneering Bioelectronics Innovation Laboratory to develop futuristic battery-free implantable medical devices in the form of chips. These chips will be used for treatment of brain, nerve, muscle or spinal cord disorders that are untreatable by using standard medical practices.

The Middle East and Africa market is developing slowly but steadily as the region is attracting new players to venture into the regional market, which is expected to intensify the competition in the market in the near future.

Key Players

Bio-Rad Laboratories Inc. (US), Cepheid (US), Abbott Laboratories (US) Agilent Technologies, Inc. (US) Perkinelmer Inc. (US), Fluidigm Corporation (US), Illumina Inc. (US), GE Healthcare (UK), Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland) are some of the companies at the forefront of the market.

Industry News

An Israeli researcher by the name of Dr. Ben Meir Maoz of Tel Aviv University’s biomedical engineering department has developed a brain chip which will allow research on the human brain at levels of detail and precision that were not previously possible. Its specialty is its ability to take a complex system such as the brain, then break it down into subunits, and still preserve the links between these subunits.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-chips-market-1310